Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (6)

2024

  1. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2017

  1. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

2012

  1. Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD

    Respiratory Research, Vol. 13

2008

  1. C-reactive protein levels and survival in patients with moderate to very severe COPD

    Chest, Vol. 133, Núm. 6, pp. 1336-1343

2000

  1. Combination therapy with interferon-α plus N-acetyl cysteine for chronic hepatitis C: A placebo controlled double-blind multicentre study

    Journal of Medical Virology, Vol. 61, Núm. 4, pp. 439-442

1997

  1. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

    Hepatology, Vol. 25, Núm. 2, pp. 470-477